Evidence map›Paper›PMID 39093479›Full record

ArticleEJNMMI radiopharmacy and chemistry2024

Cyclotron production of manganese-52: a promising avenue for multimodal PET/MRI imaging.

Francesca Porto, Sara Cisternino, Emiliano Cazzola, Giorgia Speltri, Liliana Mou, Alessandra Boschi, Lorenza Marvelli, Giovanni Di Domenico, Antonella Pagnoni, Lucia De Dominicis and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Quantification ofMedicinal research reviews · 2026
    Review
  2. Emerging Theranostic Radiometals (Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Francesca Porto *Department of Translational Medicine, University of Ferrara, Via Fossato di Mortara, 70 c/o viale Eliporto, 44121, Ferrara, Italy.
Sara Cisternino *Legnaro National Laboratories (LNL-INFN), National Institute for Nuclear Physics, Viale dell'Università, 2, 35020, Legnaro, PD, Italy.
Emiliano CazzolaIRCCS Sacro Cuore Don Calabria Hospital, Viale Luigi Rizzardi, 4, 37024, Negrar di Valpolicella, VR, Italy.
Giorgia SpeltriDepartment of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via L. Borsari, 46, 44121, Ferrara, Italy.
Liliana MouLegnaro National Laboratories (LNL-INFN), National Institute for Nuclear Physics, Viale dell'Università, 2, 35020, Legnaro, PD, Italy.
Alessandra BoschiDepartment of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via L. Borsari, 46, 44121, Ferrara, Italy. alessandra.boschi@unife.it.ORCID http://orcid.org/0000-0002-6382-1944
Lorenza MarvelliDepartment of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via L. Borsari, 46, 44121, Ferrara, Italy.
Giovanni Di DomenicoDepartment of Physics and Earth Sciences, University of Ferrara, Via Saragat, 1, 44122, Ferrara, Italy.
Antonella PagnoniDepartment of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via L. Borsari, 46, 44121, Ferrara, Italy.
Lucia De DominicisLegnaro National Laboratories (LNL-INFN), National Institute for Nuclear Physics, Viale dell'Università, 2, 35020, Legnaro, PD, Italy.
Irene CalliariDepartment of Industrial Engineering, University of Padova, Via Gradenigo, 6/a, 35131, Padua, Italy.
Claudio GennariDepartment of Industrial Engineering, University of Padova, Via Gradenigo, 6/a, 35131, Padua, Italy.
Licia UccelliDepartment of Translational Medicine, University of Ferrara, Via Fossato di Mortara, 70 c/o viale Eliporto, 44121, Ferrara, Italy.
Gaia PupilloLegnaro National Laboratories (LNL-INFN), National Institute for Nuclear Physics, Viale dell'Università, 2, 35020, Legnaro, PD, Italy.
Giancarlo GorgoniIRCCS Sacro Cuore Don Calabria Hospital, Viale Luigi Rizzardi, 4, 37024, Negrar di Valpolicella, VR, Italy.
Juan Esposito *Legnaro National Laboratories (LNL-INFN), National Institute for Nuclear Physics, Viale dell'Università, 2, 35020, Legnaro, PD, Italy.
Petra Martini *Department of Environmental and Prevention Sciences, University of Ferrara, Via L. Borsari, 46, 44121, Ferrara, Italy.

Funding

LNL-INFN CSN5University of Ferrara FAR2022
6 · The paper itself

Abstract

backgroundThe integration of positron emission tomography (PET) and magnetic resonance imaging (MRI) holds promise for advancing diagnostic imaging capabilities. The METRICS project aims to develop cyclotron-driven production of

resultsUsing the

conclusionsThe developed technology offers a promising avenue for producing

Indexed as

Cyclotron productionIon exchange chromatographyManganese-52Mn-based contrast agentsMn-radiopharmaceuticalsPET-imagingPET/MRISpark plasma sintering

Identifiers

PMID39093479
PMCPMC11297007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.